However, Zhang et al. suggested in their meta-analysis that the expression of cyclin D1 is unlikely to be useful as a prognostic marker for NSCLC in clinical practice from current evidence [72]. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.